Patent systems are first-to-file. It's produced a quiet two-tier system: well-funded companies file in 48 hours. Everyone else waits weeks.
Today we're announcing @fearn_ai's $5.5M seed to end that gap. 🧵
00:00
Fearn
6 posts
Fearn
@fearn_ai
Draft a complete application in minutes.
Joined September 2025
- Fearn reposted
congrats to Han, Angela, and team Fearn on closing their $5.5m seed round led by our friends at Kindred, Designer Fund, & Essence VC! @fearn_ai is the AI-native patent platform built for a fast-moving IP world where being first-to-file is the difference between making money offPatent systems are first-to-file. It's produced a quiet two-tier system: well-funded companies file in 48 hours. Everyone else waits weeks. Today we're announcing @fearn_ai's $5.5M seed to end that gap. 🧵00:00 - Fearn reposted
some of the most interesting innovation has always been at the edges. I did my phd in a highly interdisciplinary field called computational imaging where I worked with generative models to solve real world scientific imaging problems. I worked with domain experts to blend messyPatent systems are first-to-file. It's produced a quiet two-tier system: well-funded companies file in 48 hours. Everyone else waits weeks. Today we're announcing @fearn_ai's $5.5M seed to end that gap. 🧵00:00 - Fearn reposted
Patent systems are first-to-file. It's produced a quiet two-tier system: well-funded companies file in 48 hours. Everyone else waits weeks. Today we're announcing @fearn_ai's $5.5M seed to end that gap. 🧵00:00 - Fearn repostedwe are hiring! we're on a mission to help inventors protect their IP, which means building reliable AI systems people can actually trust. we're looking for engineers and researchers ready for a fast-paced environment where you'll work across the entire stack, take on problems
- Fearn repostedOpenAI’s CFO, Sarah Friar, just announced that OpenAI is exploring a move towards IP-based agreements as a source of revenue. As reported in Business Insider: “In one example, [Friar] pointed to drug discovery: if a pharma partner used OpenAI technology to help develop a
